Day: November 20, 2026

Access to stem cell therapy for multiple sclerosis remains tightly restricted in Canada. This guide explains why, what clinical research has found, and why Canadian MS patients are increasingly looking to Mexico for physician-guided regenerative options.
Many Canadian MS patients are traveling to Mexico after facing long wait times at home. This article explains what HSCT involves, how it differs from regenerative medicine protocols, what real patients are experiencing, and how to evaluate your options safely.
How can I help you?